Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Gennex Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:531739 P/E (TTM) :18.31
ISIN Demat:INE509C01026 Div & Yield %:0 EPS (TTM) :0.62
Book Value (RS) :7.8732292 Market Cap (Rs Cr.):258.15 Face Value (RS) :1
    Change Company 
YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.010.090.210.160.14
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio5.162.951.941.781.63
Fixed Assets2.222.262.142.101.99
Inventory4.776.2810.2310.229.39
Debtors6.617.096.448.367.19
Interest Cover Ratio13.725.896.787.844.40
PBIDTM (%)22.5911.2010.3610.497.17
PBITM (%)21.5010.169.159.115.50
PBDTM (%)21.039.479.019.335.92
CPM (%)17.037.437.227.734.77
APATM (%)15.946.396.016.353.10
ROCE (%)12.5010.6911.7813.178.31
RONW (%)9.457.419.3510.675.33

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)